Summit Therapeutics's chart data is dated 2026-10-09. Recorded technical signals: MACD bullish cross. There are 0 published signal records.
Summit Therapeutics last closed at $17.59 (+2.45%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -15.6×. Its overall grade ranks 386 of 738 stocks in Healthcare.
About this company
Summit Therapeutics last closed at $17.59 (+2.45%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 386/738
Valuation grade A
Related stocks
- IvonescimabRelated theme
Summit의 핵심 파이프라인으로, 기업 연결의 중심 축
- AkesoSupplier
ivonescimab 원개발/권리 관련 핵심 파트너로 간주되는 기업
- MerckCompetitor
폐암·면역항암제 시장에서 Summit의 주요 경쟁 축
About Summit Therapeutics
- What technical signals does Summit Therapeutics (SMMT) have?
- Summit Therapeutics current technical signals: MACD bullish cross.
- Is Summit Therapeutics a cup-and-handle pattern?
- No. Summit Therapeutics has no valid Cup signal right now.
- What published figures are available for Summit Therapeutics?
- Market cap: $13.06B. Trailing 12 months PER: -15.6×. Latest quarter PBR: 21.21×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Summit Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.